PMV Pharmaceuticals, Inc. - Common Stock - Nakit Akışı (NASDAQ:PMVP)

Financials

İşletme faaliyetlerinden elde edilen nakit -32.74 M-46.57 M-63.76 M-55.66 M-51.28 M-73.58 M -74.99 M Yatırım faaliyetlerinden elde edilen nakit 27.91 M-143.58 M-1.37 M-50.55 M53.35 M70.17 M 62.28 M Finansman faaliyetlerinden elde edilen nakit 292.97 M2.02 M958 K35.58 M313 K505 K 495 K Serbest nakit akışı -32.74 M-47.96 M-63.96 M-55.66 M-51.28 M-73.61 M -75.02 M

Haberler

PMV Pharma’nın rezatapopt çalışması New England Journal’da yayımlandı

PMV Pharma’s rezatapopt study published in New England Journal

OrbiMed Advisors, PMV Pharma (PMVP) hisselerini 1,52 milyon dolar karşılığında sattı

OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million

PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Slideshow (NASDAQ:PMVP) 2025-10-25

PMV Pharmaceuticals hisseleri olumlu kanser ilacı denemesi verileriyle yükseldi

PMV Pharmaceuticals stock rises on positive cancer drug trial data

PMV Pharma, kanser konferansında TP53 mutasyon tedavisi hakkında ilk verileri sunacak

PMV Pharma to present initial data on TP53 mutation therapy at cancer conference

PMV Pharmaceuticals hissesi, deneme verileri üzerine H.C. Wainwright’tan Al tavsiyesi aldı

PMV Pharmaceuticals stock holds Buy rating at H.C. Wainwright on trial data

PMV Pharmaceuticals, Inc. (PMVP) Special Call - Slideshow (NASDAQ:PMVP)